Gene · 4191
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term effect of fulvic acid amendment on the anammox biofilm system at 15 ℃: performance, microbial community and metagenomics analysis. | Bioresour Technol | 2022 | 34756979 | PubTator, text mining | PubMed |
| Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia. | J Clin Endocrinol Metab | 2022 | 34718610 | PubTator, text mining | PubMed |
| Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics. | Biosens Bioelectron | 2022 | 34688113 | PubTator, text mining | PubMed |
| Impact of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status. | Hepatol Commun | 2022 | 34687175 | PubTator, text mining | PubMed |
| Kinetic characterization and thermostability of C. elegans cytoplasmic and mitochondrial malate dehydrogenases. | Biochim Biophys Acta Proteins Proteom | 2022 | 34619358 | PubTator, text mining | PubMed |
| Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention. | Annu Rev Physiol | 2022 | 34614372 | PubTator, text mining | PubMed |
| An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer. | Epigenetics | 2022 | 34494499 | PubTator, text mining | PubMed |
| Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA). | AJR Am J Roentgenol | 2022 | 34431366 | PubTator, text mining | PubMed |
| Profile of the RNA in exosomes from astrocytes and microglia using deep sequencing: implications for neurodegeneration mechanisms. | Neural Regen Res | 2022 | 34380901 | PubTator, text mining | PubMed |
| Liamocins biosynthesis, its regulation in Aureobasidium spp., and their bioactivities. | Crit Rev Biotechnol | 2022 | 34154468 | PubTator, text mining | PubMed |
| Fourier-transform ion cyclotron resonance mass spectrometry for characterizing proteoforms. | Mass Spectrom Rev | 2022 | 32894796 | PubTator, text mining | PubMed |
| Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19. | Infect Dis Immun | 2021 | 38630120 | PubTator, text mining | PubMed |
| [Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma]. | Probl Endokrinol (Mosk) | 2021 | 35262293 | PubTator, text mining | PubMed |
| A Mixture of Baicalein, Wogonin, and Oroxylin-A Inhibits EMT in the A549 Cell Line via the PI3K/AKT-TWIST1-Glycolysis Pathway. | Front Pharmacol | 2021 | 35222014 | PubTator, text mining | PubMed |
| Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion. | Discov Oncol | 2021 | 35201450 | PubTator, text mining | PubMed |
| High Prevalence and Diversity Characteristics of blaNDM, mcr, and blaESBLs Harboring Multidrug-Resistant Escherichia coli From Chicken, Pig, and Cattle in China. | Front Cell Infect Microbiol | 2021 | 35198455 | PubTator, text mining | PubMed |
| Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations. | Cell Rep Med | 2021 | 35028610 | PubTator, text mining | PubMed |
| Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins? | Int J Mol Sci | 2021 | 35008448 | PubTator, text mining | PubMed |
| Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies. | Cancers (Basel) | 2021 | 35008348 | PubTator, text mining | PubMed |
| Cancer metabolism and intervention therapy. | Mol Biomed | 2021 | 35006438 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4191/papers?page=35